You searched for "trial"
Biologicals for severe chronic rhinosinusitis with nasal polyps. Any use?
Recent advances and knowledge of inflammatory endotypes of chronic rhinosinusitis with nasal polyps (CRSwNP) led to introduction of biological agents such as monoclonal antibodies targeting IgE (omalizumab) and Interleukins (ILs) such as IL4R alpha (dupilumab) and IL5. The European Academy...BSA Scientific Meeting 2023
Fiona Kukiewicz, Clinical Scientist (Audiology), Head of Clinical Services MED-EL UK & Ireland. The British Society of Audiology Scientific Meeting was a showcase for high quality research, development and service improvement. It was a chance for special interest groups (SIGs)...Nature Communications Medicine publishes positive, real-world data for tinnitus patients treated with unique, FDA approved stimulation device
Nature Communications Medicine has published the first peer reviewed, real-world analysis of U.S. patients treated with Lenire, the only FDA approved tinnitus treatment device of its kind. Results in the paper “Retrospective chart review demonstrating effectiveness of bimodal neuromodulation for...
CRSwNP, another monoclonal antibody
Interleukins 4, 5 and 13 were shown to be important factors in type 2 inflammation, which characterises chronic rhinosinusitis with nasal polyposis (CRSwNP). In CRSwNP non-responders and those who recur short after-surgery monoclonal antibodies might be an answer. Examples include...
Temperature-controlled radiofrequency treatment of the nasal valve confers sustained benefit
Aiming to investigate long-term efficacy and safety (three years post treatment), this was an extension of a previous multicentre, prospective, single-blinded, randomised controlled trial that investigated the effectiveness and safety of temperature-controlled radiofrequency treatment (TCRF) to the nasal valve (NV)...Brussels, a multicultural city with varied ENT practice
Brussels has a proud history in the world of ENT. Jérome Lechien, who is on the Communications Committee for the CEORL-HNS 2019 Congress, and Daniele de Siati, a member of the international Scientific Committee, give us a history lesson and...
Well drilling vs. subperiosteal pocket for cochlear implants – comparison of operative time, complications and cost-effectiveness
The choice of method for securing the receiver/stimulator (R/S) package during cochlear implant surgery is usually dependant on several factors, but primarily surgeon preference. The initial recommendation from manufacturers was to drill a bony well (WD technique) and use bony...Genomic testing for deafness and its implications
Gene therapies for hearing loss are rapidly advancing and will be transitioning to clinical practice. Here, the authors explain why clinicians involved in managing these disorders need to be aware of these advances. Genomic testing in England was significantly reconfigured...
Luna tunes – the plug and play audiometer from Interacoustics
“The professional grade headset designed with screening in mind.” Interacoustics Luna – does it ‘eclipse’* the competition?* * (Although we are fans of moon-based puns, this is not to be confused with Interacoustics’ other stellar device, the Eclipse Evoked Potentials...Take part in the FAMOUS study
Could your clinic be one of 40 NHS sites across the UK to participate in the FAMOUS study? Organisers need your help to improve the assessment and management of adult hearing loss.
Predicting which oropharyngeal SCC HPV-positive patients should avoid de-escalated treatment
This study is timely for many reasons and raises very important questions in the management of the current rise in HPV-positive patients with oropharyngeal cancer (OPC). The uniqueness of this group within head and neck cancer in terms of favourable...
